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ABSTRACT
Introduction Observational and intervention studies 
have verified that weight loss predicts a reduced type 2 
diabetes (T2D) risk. At the population level, knowledge on 
the prediction of self- report intentional weight loss (IWL) 
on T2D incidence is, however, sparse. We studied the 
prediction of self- report IWL on T2D incidence during a 
15- year follow- up in a general adult population.
Research design and methods The study sample from 
the representative Finnish Health 2000 Survey comprised 
4270 individuals, aged 30–69 years. IWL was determined 
with questions concerning dieting attempts and weight 
loss during the year prior to baseline. Incident T2D cases 
during a 15- year follow- up were drawn from national 
health registers. The strength of the association between 
IWL and T2D incidence was estimated with the Cox model.
Results During the follow- up, 417 incident cases of T2D 
occurred. IWL predicted an increased risk of T2D incidence 
(HR 1.44; 95% CI 1.11 to 1.87, p=0.008) in a multivariable 
model. In interaction analyses comparing individuals with 
and without IWL, a suggestively elevated risk emerged in 
men, the younger age group, among less- educated people 
and in individuals with unfavorable values in several 
lifestyle factors.
Conclusions Self- report IWL may predict an increased 
risk of T2D in long- term, probably due to self- implemented 
IWL tending to fail. The initial prevention of weight gain and 
support for weight maintenance after weight loss deserve 
greater emphasis in order to prevent T2D.
INTRODUCTION
Consistent evidence suggests that over-
weight/obesity is a major risk factor of type 
2 diabetes (T2D).1 A cohort study estimated 
that 77% of all T2D cases were attributable 
to overweight.2 Accordingly, in clinical prac-
tice, weight loss is used as the main preven-
tive factor against T2D occurrence. However, 
weight loss attempts are not limited to individ-
uals with genuine medical weight loss needs. 
Over 40% of adults report having tried to lose 
weight at some point in life.3
Systematic reviews, based on several inter-
vention studies, in which participants receive 
support on weight loss and lifestyle change 
(ie, healthy diet and physical activity (PA)), 
have shown that weight loss predicts lowered 
risk of T2D compared with not losing 
weight.4 5 In these studies, mostly including 
participants with overweight, obesity or other 
initial risk factors of T2D, active interven-
tion periods have ranged between 0.5 and 
6 years (mean 2.6, SD 1.7 years).4 In one of 
the seminal intervention studies, the Finnish 
Diabetes Prevention Study, the individuals in 
the intervention group had 58% smaller risk 
of developing T2D during a mean interven-
tion period of 3.2 years than the individuals 
in the control group,6 and the risk remained 
decreased during a 13- year total follow- up 
Significance of this study
What is already known about this subject?
 ► Successful weight loss reduces the risk of type 2 
diabetes (T2D).
 ► At population level, weight loss tends to fail, and 
intentional weight loss (IWL) and dieting attempts 
have been shown to associate with subsequent 
weight gain.
What are the new findings?
 ► At population level, self- initiated IWL seems to be 
associated with higher risk of developing T2D in long 
term.
 ► It appears that among individuals with IWL, elevated 
risk of developing T2D is indicatively pronounced in 
certain subgroups including those with unfavorable 
lifestyle habits.
 ► It seems that among individuals with overweight, 
IWL is associated with higher risk of developing T2D 
regardless of initial health conditions.
How might these results change the focus of 
research or clinical practice?
 ► Information on self- report IWL can be used to iden-
tify individuals potentially at elevated risk of gaining 
weight and developing T2D in the future.
 ► Special focus and support to learn healthy lifestyle 
should be targeted to individuals with IWL behavior 
in order to prevent future weight gain and develop-
ment of T2D.
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(HR of intervention group vs control group 0.61; 95% 
CI 0.48 to 0.79; p<0.001).7 These findings are supported 
in part8–12 but not all13–16 cohort studies with weight loss 
without information on intentionality (WLW) as an expo-
sure. In these WLW studies, as no information exists on 
the intentionality of weight loss, the weight- losers may 
also include individuals with unintentional weight loss. 
It would appear, however, that only three cohort studies 
(and all in the same cohort including individuals with 
overweight and obesity) have so far been performed on 
the prediction of intentional weight loss (IWL) on T2D 
occurrence17–19 and only one study on the prediction 
of weight control by dieting on T2D occurrence.20 The 
results of these observational studies acknowledging the 
intentionality aspect in weight loss were in line with the 
results of WLW and intervention studies.
The majority of epidemiological follow- up studies have 
suggested that dieting predicts weight gain.21–23 Some 
studies have indicated the association to be accentu-
ated in individuals with normal weight.22 23 It has been 
suggested that dieting attempts may act as a proxy for 
susceptibility to gain weight.24 This finding may also 
be due to weight loss induced autoregulated metabolic 
changes (eg, lowering of energy expenditure, hyper-
phagia), which contribute to weight regain and possible 
fat overshooting.25 Failed dieting attempts often lead 
to a subsequent attempt, and repeated attempts lead 
to weight cycling. Weight cycling, however, is not a new 
phenomenon, but already in 1962 Neel26 suggested that 
a ‘thrifty genotype’, originally beneficial for hunter- 
gatherers during cycles of feast and famine, predisposes 
its carriers to increased risk of diabetes through efficient 
utilization of food and, thus, development of obesity. 
The evidence for weight cycling causing adverse meta-
bolic changes is, however, inconsistent.27 Nevertheless, 
weight cycling seems to play a role in the development of 
chronic diseases such as T2D.28
As only a few studies exist on associations between IWL 
and T2D, and none conducted in a representative adult 
population, but in populations with overweight or obesity, 
and as the associations between dieting and weight gain 
suggest that dieting may also have adverse metabolic 
consequences, the present study aimed to investigate the 
prediction of IWL on subsequent T2D incidence during 
a 15- year follow- up in a general adult population.
RESEARCH DESIGN AND METHODS
Study population
The cohort sample used was based on the Health 2000 
Survey (BRIF8901) collected in 2000–2001.29 The nation-
ally representative adult population sample was drawn 
from the Finnish Population Information System with a 
two- stage stratified cluster sampling design and included 
8028 men and women aged 30 years and over. Of the 
original sample, 6771 (84% of the sample) participated 
in a health examination (see online supplementary 
figure S1). We excluded those with previously diagnosed 
diabetes or myocardial infarct, not within age range of 
30–69 at baseline, pregnant at baseline or with missing 
information in the variables included in the analyses (see 
online supplementary figure S1). We tested whether the 
exclusion of those having recently given birth (during 2, 
3 or 4 years before baseline) and, thus, possibly losing 
‘baby weight’ would affect the results by excluding such 
individuals from the study sample. As this did not make 
any difference, we included these women in the sample. 
After the exclusions, the study sample included 4270 
individuals (2308 women and 1962 men).
Methods
Information on variables used in this study was collected 
during a field phase including a health examination, 
interviews, and self- administered questionnaires. More-
over, information was drawn from national health 
registers.
IWL was defined by combining questions concerning 
dieting attempts during the year prior to baseline (no/
yes) and weight loss during the year prior to baseline (no/
yes) from a self- administrative questionnaire. The ques-
tionnaire included a question concerning the amount 
of weight loss during the year prior to baseline (among 
those with weight loss: range 1–38 kg, mean 5.2, SD 4.0), 
but, in line with previous studies on self- report IWL, indi-
viduals who had attempted to lose weight and had lost 
any amount of weight were considered as satisfying the 
IWL criteria, irrespective of the amount of weight lost 
during the year prior to baseline.17–19 30
Data on sex and age were obtained from the sampling 
frame. Educational attainment and smoking habits were 
asked about during an interview. Education was divided 
into a three- class variable including categories: low (did 
not graduate from upper secondary school or vocational 
school), intermediate (graduated from upper secondary 
school or vocational school) and high (graduated from 
university or university of applied sciences). Individuals 
were categorized according to their smoking status as 
never- smokers, former smokers and current smokers.
A self- administered questionnaire was used to measure 
leisure- time PA, alcohol consumption (g ethanol/week) 
and habitual sleep duration during 24 hours. PA was 
categorized in three levels: not physically active (‘low’), 
regularly engaging in light PA such as walking or cycling 
(‘moderate’) and exercising for 3 hours or more per 
week or training for competitive sports (‘regular vigorous 
training’). Individuals were categorized according to 
their alcohol consumption (g ethanol/week) as non- 
users, moderate users (1–199 for male or 1–99 for female) 
and heavy users (200 or over for male or 100 or over for 
female). Sleep duration was divided into a three- class 
variable including the categories: ‘≤6 hours’, ‘7–8 hours’ 
and ‘≥9 hours’.
A self- administered Food Frequency Question-
naire assessing habitual food intake during the last 
12 months31 32 was used to measure energy intake and 
quality of diet. Average daily intakes of food groups, 
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energy and nutrients were calculated using The National 
Food Composition Database (Fineli) and in- house soft-
ware (Finessi).33 Quality of diet was measured with The 
Alternate Healthy Eating Index (AHEI).34 In this study, 
the AHEI was constructed to suit the Finnish food culture 
while imitating the original AHEI as closely as possible.35
Data for body mass index (BMI) and metabolic factors 
was collected during a health examination. Height and 
weight were measured by trained study nurses, with the 
participants only wearing light clothing and no shoes, and 
BMI was calculated. Normal weight was defined as BMI 
<25 kg/m2, overweight as 25 ≤BMI <30 kg/m2 and obesity 
as BMI ≥30 kg/m2. As the proportion of individuals with 
underweight was small (n=29), they were included in 
the group with normal weight. Waist circumference was 
measured and abdominal obesity was, in accordance with 
the International Diabetes Federations (IDF) metabolic 
syndrome (MetS) criteria, defined as a waist circumfer-
ence of ≥80 cm for women and ≥94 cm for men.36
Blood pressure was measured twice using a standard 
mercury manometer, with 2 min intervals (Mercuro 300; 
Speidel & Keller, Jungingen, Germany). The mean of 
the two measurements was used. The use of antihyper-
tensive medication was asked about during the inter-
view. The IDF’s definition of elevated blood pressure was 
used: systolic pressure ≥130 mm Hg or diastolic pressure 
≥85 mm Hg, or use of antihypertensive medication.36
Concentrations of serum triglycerides (automated 
enzymatic method, Olympus system reagent, Germany), 
serum HDL cholesterol (enzymatic method, Roche Diag-
nostics, Mannheim, Germany) and serum fasting glucose 
(hexokinase, Olympus System Reagent, Germany) were 
determined from frozen (−70C) serum samples. Cate-
gorization of these variables was conducted according 
to threshold values for the MetS: serum triglycerides 
(mmol/L) <1.7 and ≥1.7, serum HDL cholesterol 
(mmol/L) ≥1.03 in men or ≥1.29 in women and <1.03 
in men or <1.29 in women and fasting serum glucose 
(mmol/L) <5.6 and ≥5.60.36 MetS was defined as having 
a waist circumference of ≥80 cm in women or ≥94 cm in 
men and meeting two or more of the aforementioned 
unfavorable values of serum triglycerides, serum HDL 
cholesterol, fasting serum glucose and blood pressure.36
Four variables representing different indicators of 
poor health were formed. Severe MetS was defined as 
an unfavorable value in each MetS component. Mental 
health status was determined with a self- administered 
questionnaire, including the General Health Question-
naire (GHQ).37 Individuals with a GHQ score >2 were 
categorized as having poor mental health. Self- perceived 
health was determined during an interview with a five- 
category question including the options: good, quite 
good, mediocre, quite poor, poor. Additionally, a two 
class- variable was formed including categories: 1) good, 
quite good and mediocre and 2) quite poor and poor. 
Specially trained physicians diagnosed osteoarthritis in 
the knee and hip joints during the health examination 
on the basis of physical status, symptoms and medical 
history, according to detailed written instructions with 
uniform diagnostic criteria.29
The study was conducted using a cohort study design 
with T2D incidence as the outcome. The T2D cases 
occurring during a 15- year follow- up were identified from 
nationwide registers covering information on medication 
use, hospitalization and cause of death, with the presence 
of any of the International Classification of Diseases, 
Tenth Revision codes E10–E14 (see online supplemen-
tary file S1). In Finland, under the Health Insurance 
Act, the costs of diabetes medication are reimbursed for 
patients with diabetes with a diagnosis from an attending 
physician.38 In order to receive the medication allow-
ance, the physician must provide a certificate describing 
the diagnostic criteria applied for T2D diagnosis and 
the certificate must be checked and accepted by special 
advisers at the Social Insurance Institution of Finland 
(Kela). The nationwide register of patients receiving 
diabetes medication reimbursement is maintained by 
Kela. Moreover, information from the Finnish Hospital 
Discharge Register39 and the National Causes of Deaths 
Register were used. Study participants were linked to 
these registers with a unique social security number iden-
tifying each Finnish citizen. During the 15- year follow- up, 
417 individuals (241 men and 176 women) developed 
T2D.
Statistical methods
Cox’s proportional hazards model40 was used to estimate 
the HR and its 95% CI of T2D in relation to the different 
predictors considered. The follow- up time was defined 
as the number of days from the baseline examination to 
the date of T2D occurrence, death or end of follow- up, 
whichever came first. Statistical significance was tested 
using the likelihood ratio test. Potential confounding 
factors were first selected based on the literature, and 
the variables which satisfied criteria for confounding in 
this data were included in the models.41 Since it is not 
easy to draw the line between confounding factors and 
mediators, four main effects models and one interac-
tion model were defined. The first model included age, 
sex and an exposure variable in question. The second 
model included age, sex, waist circumference and IWL. 
The third model included age, sex, IWL, education 
(low, intermediate, high), alcohol consumption (none, 
moderate, heavy), leisure time PA (low, moderate, regular 
vigorous training), smoking status (never, past, current), 
AHEI (quintiles), energy intake (quintiles), BMI (contin-
uous) and sleep duration (<6, 7–8, ≥9 hours/day). The 
fourth model included the variables of the third model 
and the variables of the MetS, that is, waist circumfer-
ence (continuous), blood pressure (raised, normal), 
serum glucose (continuous), serum triglycerides (contin-
uous) and serum HDL cholesterol (continuous). Finally, 
possible modification by sex, age, leisure time PA, body 
mass index, energy intake, AHEI, sleep duration and 
MetS on the prediction of the IWL on T2D risk was 
studied by including an interaction term between IWL 
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and the potential effect modifying factor considered in 
the fourth model.
The calculations were performed using SAS (V.9.3, SAS 
Institute, Cary, North Carolina, USA).
RESULTS
IWL was more common in women, younger individuals, 
persons with a high level of education, persons with 
higher BMI, persons with lower energy intake, persons 
with higher diet quality persons with pathological values 
in metabolic factors (table 1).
A strong and consistent association between poten-
tial risk factors of diabetes and T2D incidence was seen: 
practically all baseline variables considered concerning 
sociodemography, lifestyle, metabolism and health 
significantly predicted T2D occurrence after adjustment 
for sex and age (table 2). The only exceptions were 
energy intake and quality of diet (AHEI score).
The individuals with IWL showed a statistically signif-
icant elevated risk of T2D occurrence, with an HR of 
1.58 (95% CI 1.23 to 2.03) after adjustment for socio-
demographic status and lifestyle, including BMI (model 
3, table 3). The significance still remained after further 
inclusion of the metabolic factors in the model (model 4, 
table 3; HR 1.44; 95% CI 1.11 to 1.87). Examination of the 
association by length of follow- up showed no significant 
association during the first 5 years of follow- up (model 4, 
table 3; HR 0.94; 95% CI 0.48 to 1.84) and a significant 
association (HR 1.70; 95% CI 1.28 to 2.25) during the 
remaining part of the follow- up.
Study of interactions between IWL and potential effect 
modifying factors showed significance for age, alcohol 
consumption and AHEI (table 4). The increased risk of 
Table 1 Characteristics of the participants by IWL during the year prior to baseline (n=4270)
IWL
No (n=3712) Yes (n=558) P value for 
heterogeneityMean (SD) or %* Mean (SD) or %*
Sociodemographic factors
  Sex (% male) 47.4 35.7 <0.001
  Age (years) 47.5 (10.6) 45.9 (9.93) <0.001
  High education (%) 33.5 39.1 0.008
Lifestyle factors
  BMI (kg/m2) 26.3 (4.43) 28.7 (5.05) <0.001
  Regular vigorous training (%) 19.6 22.1 0.16
  Alcohol consumption (g ethanol/week) 81.9 (145) 86.6 (126) 0.44
  Current smoking (%) 29.9 29.3 0.76
  Energy intake (kcal/day) 2314 (785) 2242 (751) 0.04
  AHEI (score) (range 7–35) 20.9 (4.87) 22.4 (4.96) <0.001
  Sleep duration (hours) 7.45 (1.01) 7.42 (1.05) 0.59
Metabolic factors
  Waist circumference (cm) 90.7 (12.9) 96.8 (14.4) <0.001
  Elevated blood pressure (%) 55.0 58.7 0.08
  Serum triglycerides (mmol/L) 1.51 (1.02) 1.65 (0.98) 0.002
  Serum HDL cholesterol (mmol/L) 1.36 (0.38) 1.26 (0.35) <0.001
  Fasting serum glucose (mmol/L) 5.34 (0.54) 5.40 (0.94) 0.01
  MetS (IDF definition) (%) 34.8 48.5 <0.001
Indicators of poor health
  Severe MetS† (%) 4.49 5.42 0.33
  Poor mental health‡ (%) 21.6 23.6 0.28
  Poor or quite poor self- perceived health (%) 6.65 6.87 0.85
  Osteoarthritis (%) 4.38 5.88 0.11
*Adjusted for age and sex.
†Fulfillment of each MetS precondition (according to IDF definition).
‡General Health Questionnaire score >2.
AHEI, Alternate Healthy Eating Index; BMI, body mass index; HDL, high- density lipoprotein; IDF, International Diabetes Federation; IWL, 
intentional weight loss; MetS, metabolic syndrome; n, number of subjects in respective category.
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Table 2 Risk of type 2 diabetes incidence during a 15- year follow- up between categories of selected variables
n of cases
(n=417)
N at risk
(n=4270) % HR* 95% CI
Sociodemographic factors
  Sex
   Women 176 2308 54.1 1
   Men 241 1962 45.9 1.77 1.46 to 2.16
  Age (years)
   30–39 42 1215 28.5 1
   40–49 109 1287 30.1 2.58 1.81 to 3.68
   50–59 175 1083 25.4 5.23 3.74 to 7.33
   60–69 91 685 16.0 4.62 3.21 to 6.67
  Education
   Low 179 1285 30.1 1
   Intermediate 151 1523 35.7 0.91 0.72 to 1.14
   High 87 1462 34.2 0.59 0.45 to 0.77
Lifestyle factors
  BMI (kg/m2)
   <25 44 1704 39.9 1
   25–29.9 172 1704 39.9 3.33 2.38 to 4.65
   ≥30 201 862 20.2 8.59 6.18 to 11.9
  Physical activity
   Low 123 1018 23.8 1
   Moderate 232 2403 56.3 0.71 0.57 to 0.89
   Regular vigorous training 62 849 19.9 0.56 0.41 to 0.76
  Alcohol consumption
   No 111 1048 24.5 1
   Moderate 211 2531 59.3 0.82 0.64 to 1.03
   Heavy 95 691 16.2 1.35 1.01 to 1.79
  Smoking
   Never 172 2139 50.1 1
   Former smoker 110 872 20.4 1.37 1.07 to 1.76
   Current smoker 135 1259 29.5 1.57 1.24 to 1.98
  Energy intake quintiles† (kcal/day)
   First (lowest) 100 853 20.0 1
   Second 74 854 20.0 0.75 0.55 to 1.01
   Third 75 854 20.0 0.75 0.56 to 1.01
   Fourth 72 854 20.0 0.77 0.57 to 1.04
   Fifth 96 855 20.0 1.05 0.79 to 1.39
  AHEI quintiles‡
   First (lowest) 65 780 18.3 1
   Second 88 861 20.2 1.16 0.84 to 1.60
   Third 100 995 23.3 1.09 0.80 to 1.49
   Fourth 83 800 18.7 1.16 0.84 to 1.60
   Fifth 81 834 19.5 0.95 0.69 to 1.33
  Sleep duration (hours)
   ≤6 74 587 13.7 1
Continued
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T2D in those with IWL was concentrated to the younger 
age group (HR 1.95; 95% CI 1.35 to 2.81), individuals not 
using alcohol (HR 1.57; 95% CI 1.00 to 2.47) or using it 
moderately (HR 1.71; 95% CI 1.22 to 2.41), and to those 
with the lowest quality diet (HR 2.76; 95% CI 1.51 to 5.04). 
Moreover, despite the lack of significant interaction, a 
n of cases
(n=417)
N at risk
(n=4270) % HR* 95% CI
   7–8 297 3239 75.9 0.77 0.59 to 0.99
   ≥9 46 444 10.4 0.93 0.64 to 1.34
Metabolic factors
  Waist circumference (cm)
   <80 cm for women or <94 cm for men 43 1531 35.9 1
   ≥80 cm for women or ≥94 cm for men 374 2739 64.1 4.57 3.32 to 6.29
  Blood pressure
   Normal 94 1901 44.5 1
   Elevated 323 2369 55.5 2.07 1.62 to 2.65
  Serum triglycerides (mmol/L)
   <1.7 189 2993 70.1 1
   ≥1.7 228 1277 29.9 2.54 2.08 to 3.10
  Serum HDL cholesterol (mmol/L)
   ≥1.29 for women or ≥1.03 for men 186 2857 66.9 1
   <1.29 for women or <1.03 for men 231 1413 33.1 2.75 2.27 to 3.34
  Fasting serum glucose (mmol/L)
   <5.6 151 3041 71.2 1
   ≥5.6 266 1229 28.8 3.99 3.24 to 4.92
  MetS (IDF definition)
   No 100 2708 63.4 1
   Yes 317 1562 36.6 5.07 4.02 to 6.39
Indicators of poor health
  Severe MetS§
   No 336 4073 95.4 1
   Yes 81 197 4.61 4.75 3.70 to 6.10
  Mental health¶
   Good 314 3328 78.1 1
   Poor 103 931 21.9 1.26 1.01 to 1.58
  Self- perceived health
   Good, quite good or mediocre 366 3980 93.3 1
   Quite poor or poor 51 285 6.68 1.74 1.30 to 2.34
  Osteoarthritis
   No 373 4043 95.4 1
   Yes 42 194 4.58 1.68 1.21 to 2.34
*Adjusted for age and sex.
†Energy intake quintile ranges (kcal): first 732–1755 for male, 593–1613 for female; second 1756–2113 for male, 1614–1946 for female ; 
third 2114–2478 for male, 1947–2285 for female; fourth 2479–3022 for male, 2286–2677 for female; fifth 3023–6413 for male, 2678–6495 for 
female.
‡AHEI quintile ranges (points): first 7–16 for male, 7–16 for female; second 17–19 for male, 17–19 for female; third 20–22 for male, 20–22 for 
female; fourth 23–25 for male, 23–25 for female; fifth 26–34 for male, 26–35 for female.
§Fulfillment of each MetS precondition (according to IDF definition).
¶General Health Questionnaire score >2.
AHEI, Alternate Healthy Eating Index; BMI, body mass index; HDL, high- density lipoprotein; IDF, International Diabetes Federation; MetS, 
metabolic syndrome; n, number of subjects in respective category.
Table 2 Continued
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Table 4 Risk of type 2 diabetes incidence during a 15- year follow- up between those with and without IWL during the year 
prior to baseline in categories of effect modifying factors
Variable
Number of individuals
HR* 95% CI
P for 
interaction
No IWL (ref.) IWL
Cases At risk Cases At risk
Sociodemographic factors               
  Sex             0.38
   Women 138 1950 38 358 1.28 0.88 to 1.86   
   Men 190 1762 51 200 1.60 1.13 to 2.27   
  Age (years)             0.03
   30–49 108 2140 43 362 1.95 1.35 to 2.81   
   50–69 220 1572 46 196 1.12 0.78 to 1.59   
  Education             0.11
   Low 144 1148 35 137 1.70 1.15 to 2.51   
   Intermediate 117 1334 34 189 1.60 1.07 to 2.39   
   High 67 1230 20 232 0.89 0.51 to 1.54   
Lifestyle factors               
  BMI† (kg/m2)             0.54
   <25 40 1561 4 143 1.32 0.47 to 3.70   
   25–29.9 142 1463 30 241 1.36 0.90 to 2.05   
   ≥30 146 688 55 174 1.79 1.28 to 2.49   
  Physical activity             0.22
   Low 102 905 21 113 1.94 1.20 to 3.16   
   Moderate 183 2080 49 323 1.20 0.85 to 1.69   
   Regular vigorous training 43 727 19 122 1.72 0.97 to 3.06   
  Alcohol consumption             0.05
   No 84 904 27 144 1.57 1.00 to 2.47   
   Moderate 166 2211 45 320 1.71 1.22 to 2.41   
   Heavy 78 597 17 94 0.74 0.39 to 1.41   
  Smoking             0.35
   Never 136 1885 36 254 1.76 1.20 to 2.59   
   Former smoker 79 729 31 143 1.13 0.70 to 1.84   
   Current smoker 113 1098 22 161 1.39 0.87 to 2.21   
  Energy intake quintiles (kcal/day)             0.09
   First (lowest) 71 723 27 122 2.00 1.26 to 3.16   
   Second–fifth 257 2989 62 436 1.25 0.92 to 1.70   
  AHEI quintiles             0.03
   First (lowest) 51 712 14 68 2.76 1.51 to 5.04   
   Second–fifth 277 3000 75 490 1.27 0.95 to 1.68   
  Sleep duration (hours)             0.37
   ≤6 57 510 17 77 1.82 1.05 to 3.15   
   7–8 235 2815 62 424 1.28 0.93 to 1.75   
   ≥9 36 387 10 57 1.96 0.96 to 3.99   
Metabolic factors               
  MetS (IDF definition)‡             0.46
   No 81 2404 19 304 2.20 1.33 to 3.64   
   Yes 247 1308 70 254 1.77 1.35 to 2.32   
*Total model: sex, age, education, BMI, physical activity, alcohol consumption, smoking, energy intake, AHEI, sleep duration, waist circumference, elevated 
blood pressure, serum HDL cholesterol, serum triglycerides, fasting serum glucose and interaction variable in question.
†Not adjusted for waist circumference.
‡Not adjusted for BMI, waist circumference, elevated blood pressure, serum HDL cholesterol, serum triglycerides or fasting serum glucose.
AHEI, Alternate healthy eating index; BMI, body mass index; HDL, high- density lipoprotein; IDF, International Diabetes Federation; IWL, intentional weight 
loss; MetS, metabolic syndrome; n, number of subjects in respective category.
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statistically significantly increased risk in those with IWL 
could be seen in the subgroups of men, individuals with 
low or intermediate education, individuals with obesity, 
individuals with low PA, never- smokers, individuals with 
the lowest energy intake and individuals with short sleep.
Further study of the interaction between IWL and indi-
cators of poor health in persons with an elevated T2D 
risk (BMI ≥25 kg/m2) showed no significant effect modi-
fication (table 5). With only one exception regarding one 
indicator (ie, osteoarthritis), a significantly elevated risk 
of T2D was seen for IWL both among individuals having 
and not having poor health.
DISCUSSION
Findings
In this representative sample of the Finnish population, 
IWL predicted an elevated risk of T2D. This finding was 
relatively consistent. It was found in the total population 
and in several categories of the known T2D risk factors 
considered. Elevated T2D risk in individuals with IWL 
was indicatively pronounced in men, younger persons, 
less educated persons, persons with obesity, persons with 
low PA, non- alcohol and moderate alcohol consumers, 
never- smokers, persons with low energy intake, persons 
with low quality of diet and persons with short sleeping 
duration. Furthermore, the association was present in 
overweight persons irrespective of health status (ie, 
severe MetS, mental health or self- perceived health). 
The elevated risk was also seen during the different time 
intervals of the 15- year follow- up. Thus, our results can be 
generalized to a wide variety of subpopulations.
Interpretation
There are several potential explanations for our findings. 
It is well known that overweight/obesity is a major risk 
factor of T2D and it has been reported to explain 77% 
of T2D incidence.2 Even though several randomized 
controlled trials on behavioral/lifestyle interventions for 
diet and PA have shown successful weight loss and T2D 
risk reduction,4 5 weight loss and especially weight main-
tenance has appeared to be difficult for the majority of 
individuals with weight regain after weight loss.42 Accord-
ingly, large population studies have shown that IWL or 
dieting attempts predict subsequent weight gain.21–23 A 
previous study, conducted with the same but somewhat 
smaller population as used in this study, showed that 
dieting attempts and weight loss during the year prior to 
baseline were associated with increase in BMI and waist 
circumference during an 11- year follow- up.23 Hence, it 
can be assumed that weight regain occurs among those 
with IWL and developing T2D as well.
In addition to potential straightforward weight gain 
after weight loss, a further potential metabolic pathway 
between IWL and increased risk of T2D may be related to 
weight cycling, which often results from repeated weight 
loss efforts. It has been suggested that weight cycling may 
increase the risk of T2D via subsequent weight gain23 27 
or, specifically, because of accumulation of abdominal 
Table 5 Risk of type 2 diabetes incidence during a 15- year follow- up between those with and without IWL during the year 
prior to baseline in categories of different indicators of health in subjects with BMI ≥25 kg/m2 (n=2484)
Variable
Number of individuals
HR* 95% CI
P for 
interaction
No IWL (ref.) IWL
Cases At risk Cases At risk
Severe MetS†‡ 0.37
  No 216 1925 65 373 1.87 1.41 to 2.48
  Yes 63 160 16 26 2.79 1.59 to 4.90
Mental health§ 0.74
  Good 207 1638 59 305 1.57 1.14 to 2.16
  Poor 72 447 22 94 1.76 1.08 to 2.86
Self- perceived health 0.25
  Good, quite good or mediocre 243 1909 68 370 1.48 1.11 to 1.99
  Quite poor or poor 36 176 13 29 3.05 1.60 to 5.80
Osteoarthritis 0.78
  No 248 1955 73 372 1.66 1.25 to 2.21
  Yes 31 130 8 27 1.30 0.59 to 2.85
*Adjusted for sex, age, education, physical activity, alcohol consumption, smoking, energy intake, AHEI, sleep duration, elevated blood 
pressure, serum HDL cholesterol, serum triglycerides and fasting serum glucose.
†Fulfillment of each MetS precondition (according to IDF definition).
‡Not adjusted for elevated blood pressure, serum HDL cholesterol, serum triglycerides and fasting serum glucose.
§General Health Questionnaire score >2.
AHEI, Alternate healthy eating index; BMI, body mass index; HDL, high- density lipoprotein; IDF, International Diabetes Federation; IWL, 
intentional weight loss; MetS, metabolic syndrome; n, number of subjects in respective category.
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obesity,27 which is known to associate with insulin resis-
tance.26 43 Alternatively, weight cycling may affect meta-
bolic factors and, consequently, elevate the risk of T2D.44 
Although the mechanisms between weight cycling and the 
development of T2D remain partly uncertain,27 evidence 
suggesting an association between weight cycling and 
T2D occurrence is relatively consistent.28 Thus, the possi-
bility of weight cycling acting as a mediator between 
IWL and T2D cannot be ruled out. Hence, when consid-
ered together, the possibility cannot be excluded that, 
especially in general population like ours, the harmful 
effects of IWL may predominate and lead to excess T2D 
occurrence.45
In accordance with the findings from the random-
ized controlled trials,4 5 the results from the majority of 
previous cohort studies8–12 17–20 have differed from those 
of our own. The only findings from cohort studies so 
far published on the prediction of IWL on T2D occur-
rence were based on individuals with overweight in 
three substudies from the American Cancer Society’s 
Cancer Prevention Study, conducted in 1959–1972. A 
total of 43 457 women18 and 49 337 men19 aged 40–64 
years considered the T2D- related mortality, and 180 768 
men and women aged 30 years and older17 the inci-
dence of T2D during a mean follow- up of 12 years. All 
three substudies suggested IWL to predict a lowered risk 
of T2D. Accordingly, an 8- year follow- up study of 844 
Mexican- Americans from the San Antonio Heart Study 
suggested self- report weight control by dieting (without 
information on the successfulness of weight loss) to be 
associated with a decreased risk of T2D in women.20
The results of cohort studies on WLW are inconsistent. 
Approximately half of the studies reported that WLW is 
related to a reduced T2D incidence.8–12 These studies 
were all based on large samples (n=1929–114 281) from 
established cohort studies, for example, Nurses’ Health 
Study,8 The Health Professionals Follow- up Study,10 
National Health and Nutrition Examination Survey12 and 
The British Regional Heart Study.11 Other studies have 
failed to find any association between WLW and T2D.13–16
Potential reasons for the discrepant results in this study 
and those of other studies may be a lack of reliability 
and/or of validity of the IWL measure we used or of 
differences between IWL and the measures of weight loss 
and dieting used in the other studies. The overall agree-
ment between the IWL used and an intended weight loss 
of ≥5%, a measure of weight loss suggested,46 consid-
ered sufficient for diabetes prevention,47 and commonly 
used,48 was relatively good. The intraclass correlation 
coefficient between these measures, estimated as kappa, 
was 0.66 (95% CI 0.63 to 0.70). A sensitivity analysis 
showed a non- significant difference between the predic-
tion of the IWL used and the intended weight loss of ≥5% 
on diabetes outcome (p=0.10), the HRs being 1.44 (95% 
CI 1.11 to 1.87) and 1.65 (95% CI 1.21 to 2.25), respec-
tively. These results thus suggest that the IWL used (ie, 
any IWL during the year prior to baseline) is a reliable 
measure for use as a predictor of diabetes occurrence.
Other potential reasons explaining the discrepant 
results include differences in study populations, length 
of follow- up, control for confounding and definition 
of T2D. These questions are evaluated in the online 
supplementary file S1. The evaluation showed that 
despite differences in several study characteristics 
considered, the discrepant results appear to be poten-
tially explained by two factors. First, the group with IWL 
may, due to higher incidence of obesity, poor health, 
potentially higher genetic predisposition to obesity and 
T2D or pronounced health consciousness, have been 
over- represented by individuals with an elevated risk of 
T2D or an elevated risk of being diagnosed with T2D. 
Second, self- implemented IWL during the short, 1- year 
period may not have worked properly for all individuals, 
resulting in weight regain or weight cycling and, later, in 
an elevated risk of T2D. To get a deeper understanding 
on these potential reasons, the IWL/T2D association was 
studied in subgroups of the population.
Effect modification
To the best of our knowledge, this is the first study to 
investigate the modifying effects of different health, 
sociodemographic and lifestyle factors on the association 
between IWL and T2D incidence in a general population. 
As literature on effect modifiers between IWL and T2D 
is almost non- existent, we selected a priori variables for 
which it was plausible, based on their known associations 
with exposure and outcome variables, that the strength 
of association may vary from one subgroup to another.
We found some indicators of poor health, such as the 
presence of MetS predicting T2D occurrence, and to 
be more common in individuals with IWL. It is possible 
that individuals with IWL already have an elevated risk 
of T2D at baseline and try to lose weight in response to 
that. This is supported by the fact that even after adjust-
ment for age and sex the amount of IWL was greater in 
individuals later developing T2D (mean 7.16, SD 5.33 kg) 
than in individuals not developing T2D (mean 5.44, 
SD 4.12 kg) during the follow- up (p=0.0009). Also the 
finding that inclusion of the components of the MetS in 
the model attenuated the association into non- existent 
during the first 5 years of the follow- up implies that indi-
viduals with IWL indeed may initially have an elevated 
risk that explains the association in short- term. In long- 
term, however, adjustment for the components of MetS 
did not notably alter the primary results. Furthermore, in 
the interaction analyses no differences in the risk of T2D 
emerged between those with IWL and different aspects 
of poorer health and those with IWL and no such health 
conditions. It is, therefore, unlikely that poorer health at 
baseline entirely could explain the results.
Even though most of the interactions for sociode-
mographic and lifestyle risk factors remained non- 
significant, several suggestive associations, based on 
statistically significant differences between those with 
IWL and without IWL in certain subgroups, emerged. 
Moreover, these tentative associations seemed plausible 
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and conformed to associations between such sociodemo-
graphic and lifestyle risk factors as exposures and T2D 
as an outcome found in this study and in the literature. 
We found that IWL was indicatively associated with an 
elevated risk of T2D in men, in younger persons and in 
less educated persons. It is possible, that men or younger 
persons do not take their IWL as seriously as women or 
older persons and regain the weight more often. Men 
with IWL may also initially be at greater risk of T2D, 
as previous findings indicate that men do not attempt 
dieting unless they become affected by overweight49 50 
or develop an actual disease.50 The indicative associa-
tion found in less educated individuals with IWL may be 
due to more unfavorable lifestyle51 or a lack of positive 
interpersonal and intrapersonal resources52 that possibly 
lead to poorer strategies for trying to lose and maintain 
weight.
Furthermore, an indicative association was observed 
in individuals with IWL and lifestyle risk factors of T2D: 
obesity, low PA, low- quality diet and short or long sleep 
duration. Conversely, smoking or heavy alcohol consump-
tion did not show such associations. Those with obesity 
are initially at greater risk of T2D and the consequences 
of failed IWL may be decisive in the development of the 
disease. Poor lifestyle while trying to lose weight may 
predispose individuals to eventually failing in weight loss 
and regaining the weight. Moreover, an indicative asso-
ciation emerged in individuals with IWL and the lowest 
energy intake. Indeed, it is possible that too drastic a 
reduction of energy intake predisposes to relapses in 
dieting regimen.
It is thus possible that in subgroups with IWL in men, 
in younger individuals, in less educated, and in individ-
uals with unfavorable lifestyle factors long- term success 
in IWL is poorer and weight regain and weight cycling 
are more common than in those who pursue weight loss 
with healthy lifestyle, better strategies or otherwise more 
earnestly. Hence, it is plausible that poor implementa-
tion of the IWL is the leading explanation for the results 
found.
Strengths and limitations
The strengths of the current study are the representative 
population sample, the prospective study design and the 
comprehensive set of potential risk factors of T2D consid-
ered, which enabled extensive control for confounding 
factors and the opportunity to study versatile interac-
tions. The major limitations were the lack of repeatability 
data on the IWL measure, the uncertainty related to the 
validity of the measure, incomplete diagnosis and lack 
of information on amount of weight change during the 
follow- up. A significant association between IWL and T2D 
incidence was found in subgroups of several potential 
effect- modifying factors. Since a significant interaction, 
possibly due to skew distributions, was confirmed only for 
some of these variables, no firm conclusions about the 
presence of effect modification can be made.
Generalization of the results
Even though findings of this study on general adult popu-
lation imply that self- initiated and self- reported IWL is 
associated with subsequently increased risk of developing 
T2D, this result should not be used as an advice not to 
lose weight among individuals with obesity and medical 
reasons for weight loss. Weight loss, and especially weight 
maintenance are difficult, but results of several life-
style intervention studies have proved that with lifestyle 
changes and support, they are possible. Thus, special 
emphasis should be placed on weight loss and weight 
maintenance that are conducted with proper lifestyle 
changes that can be applied to for life. Healthy eating and 
enough PA are the cornerstones of the process, but the 
key is to find an individually suited, yet flexible, weight 
loss and weight maintenance supporting lifestyle that 
does not lead into total relapses and weight regain. For 
many individuals, seeking assistance from professionals 
or participating in a structured weight loss program can 
also be of help.
CONCLUSIONS
During a 15- year follow- up, IWL consistently, after exclu-
sion of the first 5 years of follow- up, predicted an elevated 
risk of T2D. This is the first cohort study on this subject 
conducted in a representative sample of a general adult 
population. In addition to the whole sample, an elevated 
risk was tentatively accentuated in certain subgroups, 
for example, in those with IWL and with less educa-
tion or unfavorable lifestyle factors, which implies that 
poorly conducted IWL may be, in particular, a risk factor 
of T2D. The increased risk may derive from weight 
gain that occurs after IWL or from weight fluctuation 
resulting from IWL and inducing unfavorable changes 
in metabolic values. On the other hand, it cannot fully 
be excluded that the increased risk observed is partly 
due to an initially higher risk of T2D among individuals 
with IWL or due to methodological factors such as more 
frequently diagnosed T2D in those with IWL.
Despite the associations found in the present study, 
dieting should not be avoided by individuals with severe 
obesity or with unfavorable metabolic values, but the 
sustainability of the weight loss should be underlined. 
Since failed weight loss seems to result in disadvantageous 
consequences, dieting should be conducted carefully 
and, in the absence of medical reasons for weight loss, it 
should be avoided. These findings call for an emphasis 
on the prevention of weight gain, throughout learning 
about healthy and weight- maintenance- supportive life-
style, and, in clinical settings, on the long- term follow- up 
and support provided after IWL in order to hinder weight 
regain and weight cycling and, thus, possibly reduce the 
risk of T2D. The novel information provided by this study, 
on individuals with IWL being at higher risk of devel-
oping T2D in the future, can also be applied, in addition 
to the more traditional risk factors, to identify high- risk 
individuals of T2D in public healthcare. Further cohort 
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studies with repeated measurements on dieting behavior 
and changes in weight, and samples large enough to 
properly enable the examination of effect modifying 
factors are needed.
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